1pharmacology
study of medications
2drug
substance capable of producing a biologic response
3medication
drug given for the purpose of producing a therapeutic resposne
4effective use of drugs & medication depends on being able to apply knowledge related to (5)
-A&P
-pathophysiology
-chemistry
-microbiology
-nursing process
5therapeutics
branch of medicine concerned with prevention of disease and treatment of suffering
6pharmacotherapuetics
refers using medications to prevent disease and treat suffering
7traditional medications
produced by a pharmaceutical manufacturer
8biologics (2)
agents produced by animal cells and microorganisms
-e.g. hormones, antibodies, vaccines
9natural health products (3)
-Natural plant extracts
-Vitamins, minerals
-Dietary supplements
10prescription drugs (2)
Require a dispensing order (prescription) from a qualified health care professional prior to patient receiving drug
-traditional medicines, biologics
11benefits of prescription drugs (3)
-Health care provider can examine patient prior to ordering medication, ensuring that order is appropriate for patient and condition
-Dose and frequency of dispensed drug can be controlled
-Patient provided with education about drug including dosing, interactions, adverse effects
12over the counter drugs (OTC) (2)
Drugs that can be obtained by patients without consultation with a health care provider
-Traditional medications, natural health products
13benefits of OTC drugs (3)
-Usually have a high margin of safety and few adverse effects
-Patients can treat themselves for common conditions by following directions on packaging
-convenience
14nomenclature of drugs
chemical, generic, trade names e.g.
Chemical: N-Acetly-para-acetylaminophenol
Generic: Acetamniophen
trade: Tylenol
15supplements (4)
-Herbal and dietary supplements are not drugs.
-Not subjected to same regulatory process
-Can cause side effects and interact with prescription and OTC drugs
-Monitoring through Health Canada food branch
16schedule 1 (2)
-requires prescription and pharmacist dispensation
-All prescription drugs, Schedule F and G, narcotics
17schedule 2
requires pharmacist dispensation
18schedule 3
available at pharmacy or pharmacy area (OTC)
19schedule 4
can be sold at any store, no professional supervision
20controlled drug and substances act (CDSA) schedules (2)
-triplicate prescription, provincial monitoring
-narcotics, amphetamines, barbiturates, etc.
21canadian drug regulations
created to protect the public from drug misuse and provide mechanism for quality assurance for safety and efficacy
22Health products and food branch (HPFB) of health canada (2)
responsible for ensuring the safety and quality of drugs, biologics, and natural health products
-standard is set by Food and Drug Act and Regulations
23therapeutic products directorate (TPD) (3)
-Federal authority that regulates pharmaceutical drugs
-Manufacturer must provide substantive evidence of a drug's safety, efficacy and quality, per Food and Drugs Act and Regulations, to TPD for approval
-TPD approval required for drug to be marketed in Canada
24biologics and genetic therapies directorate
Parallel branch to TPD that regulates biologics and radiopharmaceuticals
25Natural and Non-Prescription Health Products Directorate (2)
-parallel branch to TPD that regulates natural health products
-Not all countries have such regulations OR have different regulations ie food vs drug
26canadian drug approval process - step 1
preclinical trials using cultured cells, living tissues and small animal models
27CDAP step 2 (3 phases)
Clinical Trial Application and testing
Phase 1: healthy subjects (evaluate safety of drug and possible adverse effects)
-Phase 2: small group of patients with target condition
-Phase 2 large group of patients with target condition
28CDAP step 3 (2)
manufacturer completes New Drug Submission (NDS) to Health Canada
-Outlines test data obtained from clinical trials, indication, adverse effects, production and packaging
29CDAP step 4
committee of drug experts reviews NDS to identify benefits and risks
30CDAP step 5
Health Canada shares information about drug with health care providers and consumers
31CDAP step 6 (2)
if approved, Health Canada issues a Drug Information Number (DIN) and a Notice of Compliance to manufacturer
-Both required for marketing drug
32CDAP step 7
Health Canada continues to evaluate drug safety and efficacy through quality assurance processes
33safety after authorization
Health Canada monitors safety and effectiveness (how well it works) of drugs, devices and vaccines, called 'post-market surveillance'.